The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health ...

Dividend stocks have remained a focal point for investors, especially amid market volatility and the growing need for steady ...

The mRNA technology behind the Pfizer and Moderna vaccines are groundbreaking, but their potential goes way beyond COVID-19. They have the ability to help the body fight a multitude of diseases, from ...

Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

University of Idaho researchers found that the COVID-19 vaccine does not have any adverse effects on a mother’s breast milk.

Idaho Sen. Brandon Shippy proposes bill to ban mRNA vaccines until 2035 by incorrectly categorizing them as gene therapy, ...

Aside from Pfizer, other companies were also asked if they expect any changes from the incoming administration on vaccines. The CEO of Moderna, which created the mRNA Covid vaccine, and has other ...

It’s time for a new era of public health—where vaccines are seen as both a scientific triumph and a shared commitment to well ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

Leerink Partners analyst Mani Foroohar has maintained their bearish stance on MRNA stock, giving a Sell rating yesterday.Invest with ...

In a report released yesterday, Courtney Breen from Bernstein maintained a Hold rating on Moderna (MRNA – Research Report), with a price target ...